指南与共识艾滋病与性传播感染新发突发、热带与寄生虫病

ORCHESTRA德尔菲共识:HIV感染者SARS-CoV-2感染的临床管理

ORCHESTRA Delphi consensus: clinical management of SARS-CoV-2 infection in people with HIV.
指南 / 共识 · Clin Microbiol Infect · 2025-03-21

该研究采用三轮德尔菲法,由34名HIV与COVID-19领域专家对27个关于HIV感染者COVID-19管理的问题进行共识评估,共识阈值设为≥79.4%的同意/不同意。最终19/27个条目达成共识,形成18条最终声明,涵盖疾病进展风险、诊断与实验室流程、早期抗病毒和/或单克隆抗体治疗、皮质类固醇使用及预防策略。共识旨在为临床医生和政策制定者提供决策参考。

要点

  • 34名专家经三轮德尔菲法评估27个HIV感染者COVID-19管理问题,共识阈值≥79.4%。
  • 19/27个条目达成共识,形成18条最终声明。
  • 声明覆盖进展风险、诊断、早期治疗、皮质类固醇及预防策略五个领域。

核心结论

  • 该共识研究为临床医生在科学证据有限或存在矛盾时,管理HIV感染者的COVID-19提供决策指导。

研究设计与样本

  • 采用三轮德尔菲法,由34名HIV与COVID-19感染领域专家组成专家组。
  • 共设计27个问题,聚焦HIV感染者COVID-19管理的四个主要领域。
  • 条目获得≥79.4%专家同意或不同意即视为达成共识,并据此生成声明。

主要发现

  • 27个条目中19个达成共识,最终形成18条声明。
  • 声明涉及HIV感染者COVID-19进展为重症的风险。
  • 声明涉及COVID-19诊断与实验室流程。
  • 声明涉及抗病毒药物和/或单克隆抗体的早期治疗。
  • 声明涉及皮质类固醇的使用及COVID-19预防策略。

关键数值与推荐

  • 共识阈值:条目获得≥79.4%专家同意或不同意即认定为共识。

临床怎么用

  • 该共识可指导感染科医生在证据有限或矛盾时对HIV感染者COVID-19进行临床决策。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The interaction between HIV and COVID-19 resulted in a syndemic that showed an excess burden of disease for people with HIV (PWH). Four years of the COVID-19 pandemic have raised many unsolved questions about the optimal care of COVID-19 in PWH. METHODS: We performed a study using a three-round Delphi methodology involving a panel of physicians with expertise in HIV and COVID-19 infections. The main aim of the study was to provide recommendations on critical clinical issues of COVID-19 among PWH and to inform physicians and policy-makers for improving care and prevention of COVID-19 in PWH. A total of 27 questions were conceived, focusing on four main areas of interest in the management of COVID-19 in PWH; a panel of 34 experts in HIV and COVID-19 care expressed their level of agreement on each item. Questions that received agreement/disagreement ≥79.4% of panellists were identified and statements were generated accordingly. RESULTS: Consensus was reached on 19/27 items, resulting in 18 final statements. These statements addressed: (a) risk of COVID-19 progression to severe disease among PWH; (b) COVID-19 diagnostics and laboratory procedures; (c) early treatments with antivirals and/or monoclonal antibodies; (d) use of corticosteroids; (e) COVID-19 preventive strategies. DISCUSSION: This consensus's study guides infectious diseases physicians in making decisions regarding the care of PWH for COVID-19, where results from the scientific literature are limited or conflicting.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Tavelli A, Vergori A, Cingolani A, et al. ORCHESTRA Delphi consensus: clinical management of SARS-CoV-2 infection in people with HIV. Clin Microbiol Infect. 2025. PMID: 40122207. doi:10.1016/j.cmi.2025.03.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。